Nexinhib20
Nexinhib20 is an inhibitor that targets the interactions of Rab27a-JFC1 (IC50: 2.6 μM) and Rac-1-GTP. Nexinhib20 can inhibit neutrophil exocytosis, adhesion, and β2 integrin activation, and has anti-inflammatory activity. Nexinhib20 can be used in the research of diseases such as systemic inflammation and myocardial ischemia-reperfusion injury[1][2].
Product Specifications
CAS Number
331949-35-0
UNSPSC
12352005
Target
Integrin; Ras; Reactive Oxygen Species (ROS)
Type
Reference compound
Related Pathways
Cytoskeleton; GPCR/G Protein; Immunology/Inflammation; MAPK/ERK Pathway; Metabolic Enzyme/Protease; NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/nexinhib20.html
Purity
99.86
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(/C(N1N=CN=C1)=C/C2=CC=CC([N+]([O-])=O)=C2)C(C)(C)C
Molecular Formula
C15H16N4O3
Molecular Weight
300.31
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD45 / LCA (Leucocyte Marker) (PTPRC/1783R + PTPRC/1975R), CF647 conjugate, 0.1mg/mL
Pmel17 / gp100 / SILV (HMB45), CF640R conjugate, 0.1mg/mL
Human Lambda Light Chain (HP6054), CF640R conjugate, 0.1mg/mL
Bcl-2 (BCL2/782), CF405S conjugate, 0.1mg/mL
